Assignee
LEPU BIOPHARMA CO LTD
CN·4 granted patents·3 pending applications·14 citations·filing 2020–2025
Top patents by PatentIndex Score
7 records- 0191US11028172B1Anti-TIGIT antibodies and uses thereofLEPU BIOPHARMA CO LTD·Filed 2020·Granted Jun 8, 2021·7 cites·20 claims
- 0290US11028174B1Bifunctional molecules targeting PD-L1 and TGF-βLEPU BIOPHARMA CO LTD·Filed 2020·Granted Jun 8, 2021·6 cites·16 claims
- 0380US11014984B2Anti-CD47 antibodies and uses thereofLEPU BIOPHARMA CO LTD·Filed 2020·Granted May 25, 2021·1 cites·5 claims
- 0475US2024066121A1Anti-cd47 antibodies and uses thereofLEPU BIOPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 0569US11883495B2Anti-CD47 antibodies and uses thereofLEPU BIOPHARMA CO LTD·Filed 2021·Granted Jan 30, 2024·0 cites·8 claims
- 0656US2025154280A1Anti-glypican 3 antibodiesLEPU BIOPHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0750US2023287125A1Bifunctional molecules targeting pd-l1 and tgf-betaLEPU BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LEPU BIOPHARMA CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →